Plexus CFO Sells $732K in Stock Amidst Broader Insider Distribution Near 52-Week Highs
PLXS sits 99% above its 52-week low of $103.43 on elevated volume (2.0× avg).
Summary
Plexus Corp.'s CFO, Patrick Jermain, sold over $732,000 worth of common stock, contributing to a recent pattern of insider sales by executives while the stock trades near its 52-week high.
Key Events · Ownership and Investor Activity · PLXS
-
CFO Stock Sale
Patrick Jermain, Executive VP and CFO, disposed of 3,587 shares of Plexus Corp. common stock on February 4, 2026.
-
Significant Transaction Value
The sale was executed at an average price of $204.09 per share, totaling approximately $732,071.
-
Broader Insider Distribution
This transaction follows other recent insider dispositions, including a Form 4 from Chairman Dean A. Foate and multiple Form 144 filings from other executives, indicating a pattern of insider selling.
-
Timing Near 52-Week Highs
The sale occurred while Plexus stock is trading near its 52-week high of $208.92, potentially signaling insiders locking in gains.
Analysis · PLXS · Manufacturing
The sale of over $732,000 in common stock by CFO Patrick Jermain is a significant transaction, especially given his executive role. This Form 4 filing confirms the execution of a previously indicated intent to sell (as seen in a Form 144 filed on the same date). This disposition is part of a broader trend of insider selling at Plexus Corp. over the past 90 days, which has seen a net distribution of over $3.8 million from four active insiders. The timing of these sales, with the stock trading near its 52-week high, could suggest that executives are taking profits. Investors should monitor this pattern of insider distribution, particularly in light of the recent 10-Q filing which, despite strong revenue, showed a decline in operating and free cash flow.
At the time of this filing, PLXS was trading at $206.22 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $5.5B. The 52-week trading range was $103.43 to $208.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.